Literature DB >> 28391317

SMO mutant olfactory groove meningiomas-the next in line for targeted therapy.

Christopher Alvarez-Breckenridge1, Priscilla K Brastianos2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28391317      PMCID: PMC5464315          DOI: 10.1093/neuonc/now302

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  10 in total

1.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

Authors:  Quinn T Ostrom; Haley Gittleman; Jordonna Fulop; Max Liu; Rachel Blanda; Courtney Kromer; Yingli Wolinsky; Carol Kruchko; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-10-27       Impact factor: 12.300

2.  Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

Authors:  Matthew R Strickland; Corey M Gill; Naema Nayyar; Megan R D'Andrea; Christian Thiede; Tareq A Juratli; Gabriele Schackert; Darrell R Borger; Sandro Santagata; Matthew P Frosch; Daniel P Cahill; Priscilla K Brastianos; Fred G Barker
Journal:  J Neurosurg       Date:  2016-11-25       Impact factor: 5.115

3.  AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.

Authors:  Felix Sahm; Juliane Bissel; Christian Koelsche; Leonille Schweizer; David Capper; David Reuss; Katja Böhmer; Ulrike Lass; Tanja Göck; Katrin Kalis; Jochen Meyer; Antje Habel; Stefanie Brehmer; Michel Mittelbronn; David T W Jones; Jens Schittenhelm; Steffi Urbschat; Ralf Ketter; Stephanie Heim; Christian Mawrin; Johannes A Hainfellner; Anna-Sophie Berghoff; Matthias Preusser; Albert Becker; Christel Herold-Mende; Andreas Unterberg; Christian Hartmann; Philipp Kickingereder; V Peter Collins; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2013-10-06       Impact factor: 17.088

4.  Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.

Authors:  Victoria E Clark; E Zeynep Erson-Omay; Akdes Serin; Jun Yin; Justin Cotney; Koray Ozduman; Timuçin Avşar; Jie Li; Phillip B Murray; Octavian Henegariu; Saliha Yilmaz; Jennifer Moliterno Günel; Geneive Carrión-Grant; Baran Yilmaz; Conor Grady; Bahattin Tanrikulu; Mehmet Bakircioğlu; Hande Kaymakçalan; Ahmet Okay Caglayan; Leman Sencar; Emre Ceyhun; A Fatih Atik; Yaşar Bayri; Hanwen Bai; Luis E Kolb; Ryan M Hebert; S Bulent Omay; Ketu Mishra-Gorur; Murim Choi; John D Overton; Eric C Holland; Shrikant Mane; Matthew W State; Kaya Bilgüvar; Joachim M Baehring; Philip H Gutin; Joseph M Piepmeier; Alexander Vortmeyer; Cameron W Brennan; M Necmettin Pamir; Türker Kiliç; Richard P Lifton; James P Noonan; Katsuhito Yasuno; Murat Günel
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

5.  Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.

Authors:  David E Reuss; Rosario M Piro; David T W Jones; Matthias Simon; Ralf Ketter; Marcel Kool; Albert Becker; Felix Sahm; Stefan Pusch; Jochen Meyer; Christian Hagenlocher; Leonille Schweizer; David Capper; Phillipp Kickingereder; Jana Mucha; Christian Koelsche; Natalie Jäger; Thomas Santarius; Patrick S Tarpey; Philip J Stephens; P Andrew Futreal; Ruth Wellenreuther; Jürgen Kraus; Doris Lenartz; Christel Herold-Mende; Christian Hartmann; Christian Mawrin; Nathalia Giese; Roland Eils; V Peter Collins; Rainer König; Otmar D Wiestler; Stefan M Pfister; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2013-02-12       Impact factor: 17.088

6.  Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.

Authors:  Victoria E Clark; Akdes Serin Harmancı; Hanwen Bai; Mark W Youngblood; Tong Ihn Lee; Jacob F Baranoski; A Gulhan Ercan-Sencicek; Brian J Abraham; Abraham S Weintraub; Denes Hnisz; Matthias Simon; Boris Krischek; E Zeynep Erson-Omay; Octavian Henegariu; Geneive Carrión-Grant; Ketu Mishra-Gorur; Daniel Durán; Johanna E Goldmann; Johannes Schramm; Roland Goldbrunner; Joseph M Piepmeier; Alexander O Vortmeyer; Jennifer Moliterno Günel; Kaya Bilgüvar; Katsuhito Yasuno; Richard A Young; Murat Günel
Journal:  Nat Genet       Date:  2016-08-22       Impact factor: 38.330

7.  Recruitment of β-Arrestin into Neuronal Cilia Modulates Somatostatin Receptor Subtype 3 Ciliary Localization.

Authors:  Jill A Green; Cullen L Schmid; Elizabeth Bley; Paula C Monsma; Anthony Brown; Laura M Bohn; Kirk Mykytyn
Journal:  Mol Cell Biol       Date:  2015-10-26       Impact factor: 4.272

8.  Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Authors:  Malak Abedalthagafi; Wenya Linda Bi; Ayal A Aizer; Parker H Merrill; Ryan Brewster; Pankaj K Agarwalla; Marc L Listewnik; Dora Dias-Santagata; Aaron R Thorner; Paul Van Hummelen; Priscilla K Brastianos; David A Reardon; Patrick Y Wen; Ossama Al-Mefty; Shakti H Ramkissoon; Rebecca D Folkerth; Keith L Ligon; Azra H Ligon; Brian M Alexander; Ian F Dunn; Rameen Beroukhim; Sandro Santagata
Journal:  Neuro Oncol       Date:  2016-01-28       Impact factor: 12.300

9.  Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations.

Authors:  Priscilla K Brastianos; Peleg M Horowitz; Sandro Santagata; Robert T Jones; Aaron McKenna; Gad Getz; Keith L Ligon; Emanuele Palescandolo; Paul Van Hummelen; Matthew D Ducar; Alina Raza; Ashwini Sunkavalli; Laura E Macconaill; Anat O Stemmer-Rachamimov; David N Louis; William C Hahn; Ian F Dunn; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-01-20       Impact factor: 38.330

Review 10.  Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic Applications.

Authors:  Wenya Linda Bi; Michael Zhang; Winona W Wu; Yu Mei; Ian F Dunn
Journal:  Front Surg       Date:  2016-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.